Proteomics of the Human Placenta: Promises and Realities

Placenta

Volumn 29, Issue 2, 2008, Pages 135-143

  Robinson, J M ^a   Ackerman IV, W E ^a   Kniss, D A ^a,b   Takizawa, T ^c   Vandre D D ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Ohio State University   (United States)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Discovery based research; Placenta; Placental cell lines; Proteomics

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CYTOTROPHOBLAST; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN GENOME; IMMUNOBLOTTING; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PLACENTA; PLACENTA FUNCTION; PLACENTA PERFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CELLS, CULTURED; HUMANS; PHYSIOLOGY, COMPARATIVE; PLACENTA; PROTEOMICS;

EID: 38649086068     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2007.12.005     Document Type: Article

References (71)

1. Godovac-Zimmermann J., Kleiner O., Brown L.R., and Drukier A.K. Perspectives in spicing up proteomics with splicing. Proteomics 5 (2005) 699-709
2. Romero R., Espinoza J., Gotsch F., Kusanovic J.P., Friel L.A., Erez O., et al. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG 113 (2006) 118-135
3. Archakov A.I., and Ivanov Y.D. Analytical nanobiology for medicine diagnostics. Mol Biosyst 3 (2007) 336-342
4. Moseley F.L., Bicknell K.A., Marber M.S., and Brooks G. The use of proteomics to identify novel therapeutic targets for treatment of disease. J Pharm Pharmacol 59 (2007) 609-628
5. Morón J.A., and Devi L.A. Use of proteomics for the identification of novel targets in brain disease. J Neurochem 102 (2007) 306-315
6. Marko-Varga G., Ogiwara A., Nishimura T., Kawamaura T., Fujii K., Kawakami Y., et al. Personalized medicine and proteomics: lessons from non-small cell lung cancer. J Proteome Res 6 (2007) 2925-2935
7. Huber L.A. Is proteomics heading in the wrong direction?. Nature Rev Mol Cell Biol 4 (2003) 74-80
8. Anderson N.L., and Anderson N.G. Proteome and proteomics: new technologies, new concepts, and new ideas. Electrophoresis 19 (1998) 1853-1861
9. Corthals G.L., Wasinger V.C., Hochstrasser D.F., and Sanchez J.-C. The dynamic range of protein expression: a challenge for proteomics research. Electrophoresis 21 (2000) 1104-1115
10. Gygi S.P., Corthals G.L., Zhang Y., Rochon Y., and Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 97 (2000) 9390-9395
11. Righetti P.G., Castagna A., Herbert B., and Candiano G. How to bring the 'unseen' proteome to the limelight via electrophoretic pre-fractionation techniques. Biosci Rep 25 (2005) 3-17
12. Grabis S., Lubec G., and Fountoulakis M. Limitations of current proteomics technologies. J Chromatogr A 1077 (2005) 1-18
13. Luche S., Santoni V., and Rabilloud T. Evaluation of nonionic and zwitterionic detergents as membrane protein solubilizers in two-dimensional electrophoresis. Proteomics 3 (2003) 249-253
14. Hu Y., Huang X., Chen G.Y.J., and Yao S.Q. Recent advances in gel-based proteome profiling techniques. Mol Biotechnol 28 (2004) 63-76
15. Ahmed N., and Rice G.E. Strategies for revealing lower abundance proteins in two-dimensional protein maps. J Chromatogr B 815 (2005) 39-50
16. Zahedi R.-P., Meisinger C., and Sickmann A. Two-dimensional benzyldimethyl-n-hexadecylammonium chloride/DSD-PAGE for membrane proteomics. Proteomics 5 (2005) 3581-3588
17. Schindler J., and Nothwag H.G. Aqueous polymer two-phase systems: effective tools for plasma membrane proteomics. Proteomics 6 (2006) 5409-5417
18. Slomianny M.C., Dupont A., Bouanou F., Beseme O., Guihot A.L., Amouyel P., et al. Profiling of membrane proteins from human macrophages: comparison of two approaches. Proteomics 6 (2006) 2365-2375
19. Bodzon-Kulakowska A., Bierczynska-Krzysik A., Dylag T., Drabik A., Suder P., Noga M., et al. Methods for sample preparation in proteomics research. J Chromatogr B 849 (2007) 1-31
20. Lopez J.L. Two-dimensional electrophoresis in proteome expression analysis. J Chromatogr B 849 (2007) 190-202
21. Canas B., Pineiro C., Calvo E., Lopez-Ferrer D., and Gallardo J.M. Trends in sample preparation for classical and second generation proteomics. J Chromatogr A 1153 (2007) 235-258
22. Rabilloud T., Luche S., Santoni V., and Chevallet M. Detergents and chaotropes for protein solubilization before two-dimensional electrophoresis. Methods Mol Biol 355 (2007) 111-119
23. Rice G.E., Georgiou H.M., Ahmed N., Shi G., and Kruppa G. Translational proteomics: Developing a predictive capacity-a review. Placenta 27 Suppl. A (2006) S76-S86
24. Stasyk L.F., and Huber L.A. Zooming in: fractionation strategies in proteomics. Proteomics 4 (2004) 3704-3716
25. Dreger M. Subcellular proteomics. Mass Spectrometry Rev 22 (2003) 27-56
26. Righetti P.G., Castagna A., Herbert B., Reymond F., and Rossier J.S. Prefractionation techniques in proteome analysis. Proteomics 3 (2003) 1397-1407
27. Au C.E., Bell A.W., Gilchrist A., Hiding J., Nilsson T., and Bergeron J.J.M. Cellular proteomics to create the cell map. Curr Opin Cell Biol 19 (2007) 376-385
28. MacLellan D.L., Steen H., Adam R.M., Garlick M., Zurakowski D., Gygi S.P., et al. A quantitative proteomic analysis of growth factor-induced compositional changes in lipid rafts of human smooth muscle cells. Proteomics 5 (2005) 4733-4742
29. Gupta N., Wollscheid B., Watts J.D., Scheer B., Aebersold R., and DeFranco A.L. Quantitative proteomic analysis of B cell lipid rafts reveals that ezrin regulates antigen receptor-mediated lipid raft dynamics. Nat Immunol 7 (2006) 625-633
30. Dasari S., Pereira L., Reddy A.P., Michaels J.-E., Lu X., Jacob T., et al. Comprehensive proteomics analysis of human cervical-vaginal fluid. J Proteome Res 6 (2007) 1258-1268
31. Pereira L., Reddy A.P., Jacob T., Thomas A., Schneider K.A., Dasari S., et al. Identification of novel biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 6 (2007) 1269-1276
32. Buhimschi I., Christner R., and Buhimschi C.S. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 112 (2005) 173-181
33. Michel P.E., Crettaz D., Morier P., Heller M., Gallot D., Tissot J.-D., et al. Proteome analysis of human plasma and amniotic fluid by Off-Gel™ isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 27 (2006) 1169-1181
34. Tsangaris G.T., Karamessinis P., Kolialexi A., Garbis S.D., Antsaklis A., Mavrou A., et al. Proteomics analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 6 (2006) 4410-4419
35. Shankar R., Gude N., Cullinane F., Brennecke S., Purcell A.W., and Moses E.K. An emerging role for comprehensive proteome analysis in human pregnancy research. Reproduction 129 (2005) 685-696
36. Webster R.P., and Myatt L. Elucidation of the molecular mechanisms of pre-eclampsia using proteomics technologies. Proteomics-Clin Appl 1 (2007) 1147-1157
37. Hoang V.M., Foulk R., Clauser K., Burlinggame A., Gibson B.W., and Fisher S.J. Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 40 (2001) 4077-4086
38. Anderson J.S., Lam Y.W., Leung A.K., Ong S.E., Lyon C.E., et al. Nucleolar proteome dynamics. Nature 433 (2005) 77-83
39. Wittmann-Liebold B., Graack H.-R., and Pohl T. Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 6 (2006) 4688-4703
40. Santoni V., Molloy M., and Rabilloud T. Membrane proteins and proteomics: Un amour impossible?. Electrophoresis 21 (2000) 1054-1070
41. Sawicki G., Dakour J., and Morrish D.W. Functional proteomics of neurokinin B in the placenta indicated a novel role in regulating cytotrophoblast antioxidant defenses. Proteomics 3 (2003) 2044-2051
42. Page N.M., Woods R.J., Gardiner S.M., Lomthaisong K., Gladwell R.T., Butlin D.J., et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 405 (2000) 797-800
43. Sun L.Z., Yang N.N., De W., and Xiao Y.S. Proteomics analysis of proteins differentially expressed in pre-eclamptic trophoblasts. Gynecol Obstet Invest 64 (2007) 17-23
44. Mine K., Katayama A., Matsumura T., Nishino T., Kuwabara Y., Ishikawa G., et al. Proteome analysis of human placentae: pre-eclampsia versus normal pregnancy. Placenta 28 (2007) 676-687
45. Webster R.P., Brockman D., and Myatt L. Nitration of p38 MAPK in the placenta: association of nitration with reduced catalytic activity of p38 MAPK in pre-eclampsia. Mol Human Reprod 12 (2006) 677-685
46. Liu A.-X., Zhang W.-W., Zhou T.-H., Zhou C.-Y., Yao W.-M., Qian Y.-L., et al. Proteomics analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss. Biol Reprod 75 (2006) 414-420
47. Butt R.H., Lee M.W.Y., Pirshahid S.A., Backlund P.S., Wood S., and Coorssen J.R. An initial proteomics analysis of human preterm labor: placental membranes. J Proteome Res 5 (2006) 3161-3172
48. Vorum H., Østergaard M., Hensechke P., Enghild J.J., Riazati M., and Rice G.E. Proteomic analysis of hyperoxia-induced responses in the human choriocarcinoma cell line JEG-3. Proteomics 4 (2004) 861-867
49. Hu R., Jin H., Zhou S., Yang P., and Li X. Proteomics analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo. Placenta 28 (2007) 399-407
50. Nampoothiri L.P., Neelima P.S., and Rao A.J. Proteomic profiling of forskolin-induced differentiated BeWo cells: an in-vitro model of cytotrophoblast differentiation. Reprod BioMed Online 14 (2007) 477-487
51. Ishioka S.-I., Ezaka Y., Umemura K., Hayashi T., Endo T., and Saito T. Proteomic analysis of mechanisms of hypoxia-induced apotosis in trophoblastic cells. Int J Med Sci 4 (2007) 36-44
52. Paradela A., Bravo S.B., Henriquez M., Riquelme G., Gavilanes F., Gonzalez-Ros J.M., et al. Proteomic analysis of apical microvillous membranes of syncytiotrophoblast cells reveals a high degree of similarity with lipid rafts. J Proteome Res 4 (2005) 2435-2441
53. Carr S., Abersold R., Baldwin M., Burlinggame A., Clauser K., and Nesvizskii A. The need for guidelines in publication of peptide and protein identification data. Working group on publication for peptide and protein identification data. Mol Cell Proteomics 3 (2004) 531-533
54. Wilkins M.R., Appel R.D., Van Eyk J.E., Chung M.C.M., Görg A., Hecker M., et al. Guidelines for the next 10 years of proteomics. Proteomics 6 (2006) 4-8
55. Rabilloud T., Kieffer S., Procaccio V., Louwagie M., Courchesne P.L., Patterson S.D., et al. Two-dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: toward a human mitochondrial proteome. Electrophoresis 19 (1998) 1006-1014
56. Lescuyer P., Strub J.-M., Luche S., Diemer H., Martinez P., Van Dorsselaer A., et al. Progress in the definition of a reference human mitochondrial proteome. Proteomics 3 (2003) 157-167
57. Kell D.B., and Oliver S.G. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. BioEssay 26 (2004) 99-105
58. Jimenez V., Henriquez M., Llanos P., and Riquelme G. Isolation and purification of human plasma membrane from normal and pre-eclamptic pregnancies. Placenta 25 (2004) 422-437
59. Jacobson B.S., Stolz D.E., and Schnitzer J.E. Plasma membrane isolation using the cationic colloidal silica isolation technique. Cells. A laboratory manual (1998), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 35.1-35.14
60. Durr E., Yu J., Krasinska K.M., Carver L.A., Yates III J.R., Testa J.E., et al. Direct proteome mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nature Biotech 22 (2004) 985-992
61. Bretscher A. Microfilament structure and function in the cortical cytoskeleton. Annu Rev Cell Biol 7 (1991) 337-374
62. Fath K.R., and Burgess D.R. Not actin alone. Curr Biol 5 (1995) 591-593
63. Vandré D.D., Ackerman Jr. W.E., Kniss D.A., Tewari A.K., Mori M., Takizawa T., et al. Dysferlin is expressed in human placenta but does not associate with caveolin. Biol Reprod 77 (2007) 533-542
64. Anderson L.V.B., Davison K., Moss J.A., Young C., Cullen M.J., Walsh J., et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 8 (1999) 855-861
65. Bashir R., Britton S., Strachan T., Keers S., Vafiadaki E., Lako M., et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nature Genet 20 (1998) 37-42
66. Liu J., Aoki M., Illa I., Chenyan W., Fardeau M., Angelini C., et al. Dysferlin a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nature Genet 20 (1998) 31-36
67. Bansal Dm Miyake K., Vogel S.S., Groh S., Chen C.C., Williamson R., et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423 (2003) 168-172
68. Lennon N.J., Kho A., Backai B.J., Perlmutter S.L., Hyman B.T., and Brown Jr. R.H. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 278 (2003) 50466-50473
69. Han R., Bansal D., Miyake K., Muniz V.P., Weiss R.M., McNeil P.L., et al. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest 117 (2007) 1805-1818
70. Huppertz V., Tews D.S., and Kaufmann P. Apotosis and syncytial fusion in human placental trophoblast and skeletal muscle. Int Rev Cytol 205 (2001) 215-253
71. Abumaree M.H., Stone P.R., and Chamley L.W. An in vitro model of human placental trophoblast deportation/shedding. Mol Hum Reprod 12 (2006) 687-694